HLA expression and immunologic properties of differentiated and undifferentiated mesenchymal stem cells

被引:1411
作者
Le Blanc, K
Tammik, C
Rosendahl, K
Zetterberg, E
Ringdén, O
机构
[1] Huddinge Univ Hosp, Karolinska Inst, Dept Haematol, SE-14186 Stockholm, Sweden
[2] Huddinge Univ Hosp, Div Clin Immunol, SE-14186 Stockholm, Sweden
[3] Huddinge Univ Hosp, Ctr Allogene Stem Cell Transplantat, SE-14186 Stockholm, Sweden
关键词
D O I
10.1016/S0301-472X(03)00110-3
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective. Mesenchymal stem cells (MSC) do not elicit alloreactive lymphocyte responses due to immune modulations. We investigated the immunologic properties of MSC after differentiation along three lineages: bone, cartilage, and adipose. Methods and Results. Flow cytometry showed that undifferentiated MSC express HLA class I but not class II, although HLA class II was present intracellularly as detected by Western blot. Addition of interferon gamma (IFN-gamma) for 48 hours induced greater than 90% of cells to express HLA class II. No lymphocyte response was induced by allogeneic irradiated MSC as stimulators. Results were similar using MSC pretreated. with IFN-gamma. After growth of cells in medium to induce differentiation to bone, cartilage, or adipose for 6 or 12 days, the expression of HLA class I increased but no class II was detected on the cell surface. The ability to upregulate HLA class II on the cell surface after exposure to IFN-gamma for 48 hours was clearly diminished after the cells had been cultured in differentiation medium for 6 or 12 days, with only 10% of cells expressing HLA class II. Using MSC grown in osteogenic, chondrogenic, or adipogenic medium as stimulator cells, no lymphocyte alloreactivity was seen, even if differentiated MSC had been pretreated with IFN-gamma. MSC inhibit mixed lymphocyte cultures, particularly after osteogenic differentiation. This suppression was further enhanced by IFN-gamma. Conclusion. Undifferentiated and differentiated MSC do not elicit alloreactive lymphocyte proliferative responses and modulate immune responses. The findings support that MSC can be transplantable between HLA-incompatible individuals. (C) 2003 International Society for Experimental Hematology. Published by Elsevier Inc.
引用
收藏
页码:890 / 896
页数:7
相关论文
共 30 条
  • [1] Baboon mesenchymal stem cells can be genetically modified to secrete human erythropoietin in vivo
    Bartholomew, A
    Patil, S
    Mackay, A
    Nelson, M
    Buyaner, D
    Hardy, W
    Mosca, J
    Sturgeon, C
    Siatskas, M
    Mahmud, N
    Ferrer, K
    Deans, R
    Moseley, A
    Hoffman, R
    Devine, SM
    [J]. HUMAN GENE THERAPY, 2001, 12 (12) : 1527 - 1541
  • [2] Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo
    Bartholomew, A
    Sturgeon, C
    Siatskas, M
    Ferrer, K
    McIntosh, K
    Patil, S
    Hardy, W
    Devine, S
    Ucker, D
    Deans, R
    Moseley, A
    Hoffman, R
    [J]. EXPERIMENTAL HEMATOLOGY, 2002, 30 (01) : 42 - 48
  • [3] Transplantation of the bone marrow microenvironment leads to hematopoietic chimerism without cytoreductive conditioning
    Bingaman, AW
    Waitze, SY
    Alexander, DZ
    Cho, HR
    Lin, A
    Tucker-Burden, C
    Cowan, SR
    Pearson, TC
    Larsen, CP
    [J]. TRANSPLANTATION, 2000, 69 (12) : 2491 - 2496
  • [4] Bone regeneration by implantation of purified, culture-expanded human mesenchymal stem cells
    Bruder, SP
    Kurth, AA
    Shea, M
    Hayes, WC
    Jaiswal, N
    Kadiyala, S
    [J]. JOURNAL OF ORTHOPAEDIC RESEARCH, 1998, 16 (02) : 155 - 162
  • [5] The effect of implants loaded with autologous mesenchymal stem cells on the healing of canine segmental bone defects
    Bruder, SP
    Kraus, KH
    Goldberg, VM
    Kadiyala, S
    [J]. JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME, 1998, 80A (07) : 985 - 996
  • [6] BRUDER SP, 1997, J CELL BIOCHEM, V64, P377
  • [7] Skeletal muscle repair by adult human mesenchymal stem cells from synovial membrane
    De Bari, C
    Dell'Accio, F
    Vandenabeele, F
    Vermeesch, JR
    Raymackcrs, JM
    Luyten, FP
    [J]. JOURNAL OF CELL BIOLOGY, 2003, 160 (06) : 909 - 918
  • [8] Mesenchymal stem cells: Biology and potential clinical uses
    Deans, RJ
    Moseley, AB
    [J]. EXPERIMENTAL HEMATOLOGY, 2000, 28 (08) : 875 - 884
  • [9] Mesenchymal stem cells are capable of homing to the bone marrow of non-human primates following systemic infusion
    Devine, SM
    Bartholomew, AM
    Mahmud, N
    Nelson, M
    Patil, S
    Hardy, W
    Sturgeon, C
    Hewett, T
    Chung, T
    Stock, W
    Sher, D
    Weissman, S
    Ferrer, K
    Mosca, J
    Deans, R
    Moseley, A
    Hoffman, R
    [J]. EXPERIMENTAL HEMATOLOGY, 2001, 29 (02) : 244 - 255
  • [10] Mesenchymal stem cells distribute to a wide range of tissues following systemic infusion into nonhuman primates
    Devine, SM
    Cobbs, C
    Jennings, M
    Bartholomew, A
    Hoffman, R
    [J]. BLOOD, 2003, 101 (08) : 2999 - 3001